AVEO PHARMACEUTICALS, INC. 4/A SEC Filings

Filed On	Filing
14 Jun 2019	Form 4/A: Young Robert C, Director Granted 40,000 Stock Option (right to buy)
03 Oct 2012	Form 4/A: Robinson Murray O., SVP, Translational Medicine Received 37,500 shares by exercise or conversion ($75K)
13 Mar 2012	Form 4/A: Gyuris Jeno, SVP, Chief Scientific Officer Sold 3,000 shares ($39.5K) · Sold 2,000 shares ($26K)
09 Feb 2012	Form 4/A: Kucherlapati Raju S, Director Acquired 14,142 shares (Other Transaction) · Disposed of 14,142 shares (Other Transaction) · Bought 15,000 shares ($217K)
22 Mar 2011	Form 4/A: Cole Douglas G., Director Sold 25,838 shares ($386K)
22 Mar 2011	Form 4/A: Cole Douglas G., Director Received 819,915 shares by conversion
18 Mar 2011	Form 4/A: Ezickson Elan, Chief Business Officer Sold 2,500 shares ($35.7K)
09 Mar 2011	Form 4/A: Cole Douglas G., Director Sold 6,294 shares ($94K) · Sold 27,400 shares ($409K)
09 Mar 2011	Form 4/A: Cole Douglas G., Director Received 819,915 shares by conversion
15 Feb 2011	Form 4/A: Ha Ngoc Tuan, Director Acquired 29,670 shares (Other Transaction) · Acquired 217 shares (Other Transaction)

Comments